RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETES
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETES
Authors
Keywords
-
Journal
Endocrine Practice
Volume 27, Issue 1, Pages 38-43
Publisher
Elsevier BV
Online
2021-01-01
DOI
10.1016/j.eprac.2020.11.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus
- (2019) Rucha J. Mehta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hypoglycaemia is reduced with use of inhaled Technosphere ® Insulin relative to insulin aspart in type 1 diabetes mellitus
- (2019) E. R. Seaquist et al. DIABETIC MEDICINE
- Current therapeutic strategy in the nasal delivery of insulin: recent advances and future directions
- (2018) Jiawei Chen et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study
- (2018) Halis Kaan Akturk et al. Diabetes Technology & Therapeutics
- EFFECT OF TOTAL DAILY DOSE ON EFFICACY, DOSING, AND SAFETY OF 2 DOSE TITRATION REGIMENS OF HUMAN REGULAR U-500 INSULIN IN SEVERELY INSULIN-RESISTANT PATIENTS WITH TYPE 2 DIABETES
- (2016) Carol Wysham et al. Endocrine Practice
- Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial
- (2015) Bruce W. Bode et al. DIABETES CARE
- Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents
- (2015) Julio Rosenstock et al. DIABETES CARE
- Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart
- (2015) T. Heise et al. DIABETES OBESITY & METABOLISM
- U300, a novel long-acting insulin formulation
- (2014) Gemma Sutton et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Technosphere Insulin Effectively Controls Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus
- (2012) Howard Zisser et al. Diabetes Technology & Therapeutics
- New ways of insulin delivery
- (2011) L. Heinemann INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Relationship of Insulin Dose, A1c Lowering, and Weight in Type 2 Diabetes: Comparing Insulin Glargine and Insulin Detemir
- (2010) George Dailey et al. Diabetes Technology & Therapeutics
- Effect of Technosphere Inhaled Insulin on Quality of Life and Treatment Satisfaction
- (2010) Mark Peyrot et al. Diabetes Technology & Therapeutics
- Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
- (2010) Julio Rosenstock et al. LANCET
- Safety and Efficacy of Inhaled Human Insulin (Exubera) During Discontinuation and Readministration of Therapy in Adults with Type 2 Diabetes: A 3-Year Randomized Controlled Trial
- (2009) Julio Rosenstock et al. Diabetes Technology & Therapeutics
- Time–Action Profile and Patient Assessment of Inhaled Insulin via the Exubera Device in Comparison with Subcutaneously Injected Insulin Aspart via the FlexPen Device
- (2009) Thomas Forst et al. Diabetes Technology & Therapeutics
- Safety and efficacy of inhaled human insulin (Exubera®) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial
- (2008) Jay S. Skyler et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Inhaled human insulin (Exubera®): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus
- (2008) Katrin E Schimke et al. Expert Review of Clinical Pharmacology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started